Comment on

• A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

  Addona TA, Shi X, Keshishian H, Mani DR, Burgess M, Gillette MA, Clauser KR, Shen D, Lewis GD, Farrell LA, Fifer MA, Sabatine MS, Gerszten RE, Carr SA. Addona TA, et al. Nat Biotechnol. 2011 Jun 19;29(7):635-43. doi: 10.1038/nbt.1899. Nat Biotechnol. 2011. PMID: 21685905 Free PMC article.
• A targeted proteomics-based pipeline for verification of biomarkers in plasma.

  Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, Yan P, Schoenherr RM, Zhao L, Voytovich UJ, Kelly-Spratt KS, Krasnoselsky A, Gafken PR, Hogan JM, Jones LA, Wang P, Amon L, Chodosh LA, Nelson PS, McIntosh MW, Kemp CJ, Paulovich AG. Whiteaker JR, et al. Nat Biotechnol. 2011 Jun 19;29(7):625-34. doi: 10.1038/nbt.1900. Nat Biotechnol. 2011. PMID: 21685906 Free PMC article.